ELTX Elicio Therapeutics Inc

$ELTX I just doubled down here. I think the re-rating has run its course, and given that MOS from the previous trial is still evolving, Checkpoint + vaccine looks very encouraging, and the technology is very robust across many indications. I think this is a very interesting entry point.

$ELTX A sub asked me about this one, So this fade is fundamentally driven by its mid-June 2026 Phase 2 AMPLIFY-7P trial failure where lead asset ELI-002 7P missed its primary disease-free survival endpoint in pancreatic cancer, triggering a 72% single-day stock collapse. With the core pipeline candidate severely compromised, the pre-revenue biotech firm faced urgent cash runway pressures that forced a $15 million registered direct offering in July 2026 this is diluting like no tomorrow. They only have enough to keep the lights on until Q4 2026 This will probably see 1$ very soon It is not a buy here